SocietyBig pharma accused of ‘free-riding on nature’ as global fund attracts just $7,000

The Cali Fund, which aims to raise $1bn annually for biodiversity by asking businesses that profit from nature’s genetic resources to support conservation in low-income countries, remains nearly empty. At the start of the COP17 biodiversity summit in Armenia, it had received $10,656 in commitments, with $7,085 deposited; no major pharmaceutical company had contributed.

Cali Fundpharmaceutical industrybiodiversityconservation

TThe Guardian★★★☆☆2026-10-22 09:00Original